Anzeige
Mehr »
Login
Samstag, 28.09.2024 Börsentäglich über 12.000 News von 691 internationalen Medien
Von 0,059 € auf 0,26 €: Die Gold-Aktie, die alle Erwartungen übertrifft
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
522 Leser
Artikel bewerten:
(2)

J.F. Lehman & Company Announces Recent Promotions and New Hires

NEW YORK, Feb. 15, 2024 /PRNewswire/ -- J.F. Lehman & Company ("JFLCO"), a leading middle-market private equity firm focused exclusively on the aerospace, defense, maritime, government and environmental sectors, is pleased to announce several promotions and new hires.

J.F. Lehman & Company logo.

Promotions effective January 2024 included Nicholas J. Andonian, James G. Dudzik and Jake T. Korek to Senior Associate. "We are pleased to recognize the skills, dedication and contributions that Nick, James and Jake have made since joining the firm nearly three years ago," said Glenn M. Shor, Partner. "Their success is yet another example of our strong track record of developing talent and rewarding excellence."

The firm also recently announced the addition of Georgia C. Cochrane as Deputy Chief Compliance Officer, Leon D. Frohlich as Director of Credit Operations & Finance and Tony C. Blackthorn and Jordan M. Janoff as Associates. "The firm remains committed to proactively onboarding talented professionals to support our continued growth and success," said Louis N. Mintz, Partner. "We anticipate the added depth, fresh perspectives and further enhancement of our functional areas will translate into value across the organization."

Recent Promotions

Nicholas J. Andonian, Senior Associate. Prior to joining the firm in 2021 as an Associate, Mr. Andonian began his career at Goldman Sachs as an Investment Management Analyst before transitioning to the Cross Markets Group in the Investment Banking Division. He graduated magna cum laude from Middlebury College, where he earned a B.A. in economics with a minor in Spanish.

James G. Dudzik, Senior Associate. Prior to joining the firm in 2021 as an Associate, Mr. Dudzik began his career as an Investment Banking Analyst in Houlihan Lokey's Global Industrials Group. He graduated from the University of Virginia, where he earned a B.A. in economics.

Jake T. Korek, Senior Associate. Prior to joining the firm in 2021 as an Associate, Mr. Korek began his career as an Investment Banking Analyst in Wells Fargo's Industrials Group. He graduated from the University of Virginia, where he earned a B.S. in commerce with a concentration in finance and a track in real estate.

Recent Team Additions

Georgia C. Cochrane, Deputy Chief Compliance Officer. Prior to joining the firm, Ms. Cochrane most recently served as the Chief Compliance Officer for the Chief Investment Office of Prudential Financial. Ms. Cochrane was previously the Chief Compliance Officer for registered entities of Guggenheim Partners LLC and has held numerous compliance-related roles at Invesco, AIG Investments, and Morgan Stanley. She graduated from Rutgers University, where she earned a B.A. in political science.

Leon D. Frohlich, Director of Credit Operations & Finance. Prior to joining the firm, Mr. Frohlich served as a Director of Operations at Olympus Peak Asset Management. Previously, Mr. Frohlich held various operations roles, including Head of US Operations at Silver Ridge Assessment Management, Credit Trading Assistant at Apollo Global Management, Credit Operations Analyst at Fortress Investment Group. He began his career in operations at International Fund Services. He earned a B.A. in finance from the University of Massachusetts, Amherst and an M.B.A. and M.S. in finance from Boston College. Mr. Frohlich is a Chartered Alternative Investment Analyst (CAIA).

Tony C. Blackthorn, Associate. Prior to joining the firm, Mr. Blackthorn was an Investment Banking Analyst in William Blair's Technology Group. Mr. Blackthorn began his career as a Financial Analyst at PSA Airlines. He earned a B.S. in finance from Wright State University and an M.S. in finance from Indiana University, Kelley School of Business.

Jordan M. Janoff, Associate. Prior to joining the firm, Mr. Janoff began his career as an Investment Banking Analyst in Deutsche Bank's Global Industrials Group, where he covered the transportation, logistics, airline and automotive industries and was promoted to Associate. He graduated magna cum laude from the University of Arizona, where he earned a B.S.B.A. in finance.

About J.F. Lehman & Company, Inc.

Founded in 1992, J.F. Lehman & Company focuses exclusively on investing in the aerospace, defense, maritime, government and environmental industries. The firm has offices in New York and Washington, D.C.
http://www.jflpartners.com

Logo - https://mma.prnewswire.com/media/349934/j_f__lehman___company_logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/jf-lehman--company-announces-recent-promotions-and-new-hires-302063209.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.